Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph
30 août 2022 06h45 HE | Seraxis, Inc.
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) -- The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an...
Needle-Free Platelet-Rich Plasma Grows Hair Through Thulium Laser Technology
17 août 2022 14h00 HE | Regeneris Boston
WESTWOOD, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Ryan Welter, MD, Ph.D., of Regeneris Medical Boston, has introduced a novel way to stimulate hair growth in men and women using growth factors from...
Regenics Updates Healthcare with Preventative and Regenerative Products and Services
03 août 2022 09h00 HE | Regenics
LOS ANGELES, Aug. 03, 2022 (GLOBE NEWSWIRE) -- How many times have patients walked into a hospital and felt at home? How often have they left the doctor's office feeling younger and re-energized? It...
Global Stem Cells Group Expands Its Stem Cell Therapy and Regenerative Medicine Centers to Indonesia
01 août 2022 07h00 HE | Meso Numismatics, Inc.
LAS VEGAS, NV, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a technology company specializing in Biotech and Numismatics,...
Cells for Cells logo.png
CELLS for CELLS treats the first-ever patient with an exosome-produced therapy for osteoarthritis
18 juil. 2022 15h54 HE | Cells for Cells
SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- Cells for Cells ("C4C"), a clinical-stage biotech pioneering allogeneic stem cell and stem-cells-derived therapeutics for high-impact chronic...
Surrozen Logo FINAL Large-1.png
Surrozen Initiates Dosing in Phase 1 Clinical Trial of SZN-043 for Severe Alcoholic Hepatitis
13 juin 2022 08h00 HE | Surrozen, Inc.
SZN-043 is a novel hepatocyte-specific R-spondin mimetic bispecific fusion protein targeting ASGR1First part of two-part Phase 1 trial starts in healthy volunteers SOUTH SAN FRANCISCO, Calif., June...
Royal Biologics Announces FDA 510K Approval and U.S. Commercial Launch of the MAXX™-BMC Bone Marrow Aspirate Concentration System
01 juin 2022 09h00 HE | Royal Biologics
HACKENSACK, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Royal Biologics (Hackensack, NJ), a company specializing in Advanced Cellular Technologies & Enhanced Autologous Healing, announces today the...
The American Academy of Stem Cell Physicians Adds Three Workshops to the June 17-19, 2022 Conference
24 mai 2022 10h00 HE | The American Academy of Stem Cell Physicians
MIAMI, May 24, 2022 (GLOBE NEWSWIRE) -- The American Academy of Stem Cell Physicians has added three new workshops to its long-awaited conference this June 17-19, 2022. The hands-on workshops will...
FBI LOGO TM.png
(26.1% CAGR) Regenerative Medicine Market Size [2021-2026] to Reach USD 151949.5 Million
18 mai 2022 06h11 HE | Fortune Business Insights
Pune, India, May 18, 2022 (GLOBE NEWSWIRE) -- The global regenerative medicine market is likely to expand considerably in the coming years due to growing applications in the treatment of chronic...
State-of-the-Art Regenerative Hands-on Workshops This June, Hosted by the American Academy of Stem Cell Physicians
16 mai 2022 10h00 HE | The American Academy of Stem Cell Physicians
MIAMI, May 16, 2022 (GLOBE NEWSWIRE) -- Distinguished physician Dr. Warren J. Bleiweiss, a triple medical board certified from the American Academy of Stem Cell Physicians, American Board of...